Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The

Tetrafecta inguinal lymphadenectomy penile cancer surgical quality survival

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
03 02 2023
Historique:
received: 27 12 2022
revised: 23 01 2023
accepted: 30 01 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

To optimize results reporting after penile cancer (PC) surgery, we proposed a A purpose-built multicenter, multi-national database was queried for stage I-IIIB PC, requiring inguinal lymphadenectomy (ILND), from 2015 onwards. Kaplan-Meier (KM) method assessed differences in OS between patients achieving A total of 154 patients were included in the analysis. The 45 patients (29%) that achieved the Our

Sections du résumé

BACKGROUND
To optimize results reporting after penile cancer (PC) surgery, we proposed a
METHODS
A purpose-built multicenter, multi-national database was queried for stage I-IIIB PC, requiring inguinal lymphadenectomy (ILND), from 2015 onwards. Kaplan-Meier (KM) method assessed differences in OS between patients achieving
RESULTS
A total of 154 patients were included in the analysis. The 45 patients (29%) that achieved the
CONCLUSIONS
Our

Identifiants

pubmed: 36826107
pii: curroncol30020146
doi: 10.3390/curroncol30020146
pmc: PMC9954864
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1882-1892

Commentaires et corrections

Type : CommentIn

Références

BJU Int. 2015 Apr;115(4):613-8
pubmed: 24947014
Clin Genitourin Cancer. 2018 Apr;16(2):e257-e261
pubmed: 29126815
Adv Anat Pathol. 2021 Jul 1;28(4):209-227
pubmed: 34050061
Transl Androl Urol. 2021 May;10(5):2264-2271
pubmed: 34159108
Urology. 2010 Aug;76(2 Suppl 1):S2-6
pubmed: 20691882
Discov Oncol. 2021 Jul 19;12(1):22
pubmed: 35201454
Urol Oncol. 2018 Feb;36(2):82.e7-82.e15
pubmed: 29153943
Surg Gynecol Obstet. 1948 Dec;87(6):679-94
pubmed: 18120502
Int Braz J Urol. 2018 May-Jun;44(3):645-646
pubmed: 29064655
Urol Clin North Am. 2011 Nov;38(4):459-69, vi-vii
pubmed: 22045177
BJU Int. 2006 Mar;97(3):655-67
pubmed: 16469049
J Urol. 2012 Sep;188(3):803-8
pubmed: 22818137
Urology. 1997 Oct;50(4):593-6
pubmed: 9338738
Eur Urol. 2015 Jan;67(1):142-150
pubmed: 25457021
Eur Urol. 2008 Oct;54(4):885-90
pubmed: 18502024
J Urol. 2003 Sep;170(3):783-6
pubmed: 12913697
J Urol. 2018 May;199(5):1238-1244
pubmed: 29248557
Eur J Cancer. 2013 Apr;49(6):1414-21
pubmed: 23231984
BJU Int. 2016 Feb;117(2):287-92
pubmed: 25395083
Transl Androl Urol. 2020 Dec;9(6):3210-3218
pubmed: 33457292
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Urology. 2005 Dec;66(6):1292-5
pubmed: 16360459
Urol Oncol. 2017 Aug;35(8):531.e9-531.e14
pubmed: 28363474
Eur Urol. 2007 Sep;52(3):893-8
pubmed: 17275169
J Urol. 1988 Aug;140(2):306-10
pubmed: 3398125
Int Urol Nephrol. 2016 Mar;48(3):363-6
pubmed: 26660956
Eur Urol. 2009 Nov;56(5):821-8
pubmed: 19640633
Urol Oncol. 2021 Dec;39(12):839.e1-839.e8
pubmed: 34400069
Eur Urol. 2009 May;55(5):1075-88
pubmed: 19264390
J Endourol. 2011 Apr;25(4):607-10
pubmed: 21226622
Front Oncol. 2021 Jul 07;11:706531
pubmed: 34307174
Urol Oncol. 2019 Sep;37(9):578.e11-578.e19
pubmed: 31296420
Int Braz J Urol. 2006 May-Jun;32(3):316-21
pubmed: 16813678
Clin Genitourin Cancer. 2017 Dec;15(6):670-677.e1
pubmed: 28522287
Transl Androl Urol. 2020 Dec;9(6):3191-3194
pubmed: 33457290
Adv Ther. 2020 Dec;37(12):4969-4980
pubmed: 33038006
Urol Oncol. 2022 Mar;40(3):112.e11-112.e22
pubmed: 34895995
Curr Oncol. 2022 Aug 01;29(8):5466-5474
pubmed: 36005170
World J Urol. 2019 Aug;37(8):1649-1657
pubmed: 30377813
Front Oncol. 2021 Nov 29;11:759362
pubmed: 34912711
Minerva Urol Nefrol. 2020 Feb;72(1):82-90
pubmed: 31833720
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
Cancer. 2010 Jun 15;116(12):2960-6
pubmed: 20564401
BJU Int. 2012 Dec;110(11):1792-5
pubmed: 22551234
BJU Int. 2005 Mar;95(4):517-21
pubmed: 15705071
J Urol. 2007 Mar;177(3):947-52; discussion 952
pubmed: 17296384
Eur Urol. 2008 Jul;54(1):161-8
pubmed: 18440124
Minerva Urol Nefrol. 2019 Dec;71(6):590-596
pubmed: 31619034
Eur Urol. 2003 Dec;44(6):656-60
pubmed: 14644116
J Urol. 2018 May;199(5):1233-1237
pubmed: 29132984
Eur Urol. 2013 Sep;64(3):486-92
pubmed: 23490726
J Urol. 2002 Apr;167(4):1638-42
pubmed: 11912379
BJU Int. 2006 Jun;97(6):1225-8
pubmed: 16686716
Actas Urol Esp. 2013 Nov-Dec;37(10):663-6
pubmed: 23768501
J Urol. 2006 Aug;176(2):575-80; discussion 580
pubmed: 16813892
Adv Urol. 2011;2011:952532
pubmed: 22110493

Auteurs

Aldo Brassetti (A)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Umberto Anceschi (U)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Gabriele Cozzi (G)

Department of Urology, European Institute of Oncology, 20141 Milan, Italy.

Julian Chavarriaga (J)

Division of Urology, Clinica Imbanaco, Quiron Salud, Cali 760042, Colombia.
Division of Urology, Pontificia Universidad Javeriana, Bogota 110231, Colombia.

Pavel Gavrilov (P)

Department of Urology, Fondacio Puigvert, 08025 Barcelona, Spain.

Josep Maria Gaya Sopena (JM)

Department of Urology, Fondacio Puigvert, 08025 Barcelona, Spain.

Alfredo Maria Bove (AM)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Francesco Prata (F)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Mariaconsiglia Ferriero (M)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Riccardo Mastroianni (R)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Leonardo Misuraca (L)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Gabriele Tuderti (G)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Giulia Torregiani (G)

Department of Anesthesiology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Marco Covotta (M)

Department of Anesthesiology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Diego Camacho (D)

Division of Urologic Oncology Instituto Nacional de Cancerologia, Bogota 111511, Colombia.

Gennaro Musi (G)

Department of Urology, European Institute of Oncology, 20141 Milan, Italy.

Rodolfo Varela (R)

Division of Urologic Oncology Instituto Nacional de Cancerologia, Bogota 111511, Colombia.

Alberto Breda (A)

Department of Urology, Fondacio Puigvert, 08025 Barcelona, Spain.

Ottavio De Cobelli (O)

Department of Urology, European Institute of Oncology, 20141 Milan, Italy.

Giuseppe Simone (G)

Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00144 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH